Multiple Sclerosis

Multiple sclerosis (MS) is an inflammatory disease affecting the brain and/or spinal cord. MS often affects younger patients with an average age at onset of 34 years. The most common form of MS is characterized by exacerbations of inflammation affecting the nervous system followed by improvement. Although the disease may affect almost any portion of the brain or spinal cord, several symptoms occur more often than others. Visual loss (due to optic neuritis) and double vision are very common in MS patients. Exacerbations are often treated with a short course of steroids, while prophylactic/protective medications are used to decrease the chances of future exacerbations. These protective medications include interferon, glatiramer acetate, natalizumab, fingolimod, teriflunomide, dimethyl fumarate.

Additional information can be found on these websites:

Developed by DECS | Contact Information | Privacy Statement | Site Accessibility

MSU is an affirmative action, equal opportunity employer

© Michigan State University Board of Trustees, East Lansing, MI 48824